# FDA Inspection 1321752 - American Red Cross Blood Services - June 10, 2026

Source: https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services/ec9aa8e9-4ddb-4179-8c43-d391abb76cfd
Source feed: FDA_Inspections

> FDA Inspection 1321752 for American Red Cross Blood Services on June 10, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1321752
- Company Name: American Red Cross Blood Services
- Inspection Date: 2026-06-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1156498 - 2021-11-08](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services/425fc831-b5d4-47a3-8053-7aeb97eb01ed)
- [FDA Inspection 1156498 - 2021-11-08](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services/c320cae0-0adf-4644-90d3-c34f28a39fe5)

Company: https://www.keypedia.com/companies/american-red-cross-blood-services/2b128ca5-4241-4729-9dab-e0f51e0d0f71

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d